Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is common in infertile women and obese women with PCOS have more severe ovulatory problems, needing more care.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Men and women react differently to opioids, with hormones potentially influencing these differences.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Quercetin may help with PCOS symptoms, but more research is needed.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Cyclosporin extends hair growth in mice, but high-dose corticosteroids block this effect.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Kolaviron and quercetin may help treat prostate issues.

Women with PCOS may be more likely to have gum disease than healthy women.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.